Eight Hashish Shares Ablaze Throughout Christmas Week

NEPT has launched brand new cannabis pre-roll products in Canada

Welcome back to our weekly series, Schaeffer’s Cannabis Stock News Update, where we round up what happened in the world of marijuana stocks and look ahead to how the cannabis industry will continue until the close of 2021.

Investor interest in the cannabis industry is growing explosively, and leading players continue to break legal barriers after legal barriers, particularly in the United States. By the end of 2020, more than 40 US states had legalized recreational and / or medical marijuana. Now companies see opportunities in cannabis cultivation, marketing, distribution and technology.

Here’s a quick recap of the top (and actionable!) Cannabis stock news of the past week:

Bright and early on Monday morning Neptune Wellness Solutions Inc. (NASDAQ: NEPT) confirmed the exclusive launch of Mood Ring’s latest cannabis pre-roll product in Canada in January. With the introduction of these pre-roll products, NEPT officially offers products in all major cannabis product categories. According to Neptune, “With sales growing nearly 200% year over year, pre-rolls have become one of the top three best-selling product categories in Ontario as consumers increasingly seek them for their accessibility and convenience.”

The shares of Canopy Growth Corp (NASDAQ: CGC) declined 5.8% on Monday morning after Piper Sandler downgraded CGC from neutral to underweight. The company also cut its price target from $ 11 to $ 7, with Piper Sandler specifically highlighting a number of revenue trends that are under pressure in Canopy Growth’s businesses.

InMed Pharmaceuticals (NASDAQ: INM) held its annual general meeting last week, which ended with the approval of the election of all board candidates. In more interesting news, the INM announced Monday that it had published a peer-reviewed journal article focusing on the treatment options for glaucoma through the use of cannabinol.

Later that day on December 20th, cbdMD, Inc. (NASDAQ:YCBD) released its financial results for the fourth quarter and fiscal year 2021. Notably, YCBD broke its net sales record after producing $ 44.5 million in fiscal year 2021. While a number of cannabis industry companies battled for movement, cbdMD outperformed the industry average.

The Valens Company Inc. (NASDAQ: VLNS) announced that it has entered into two partnership agreements with PMI Mexico. PMI Mexico is one of the largest Mexican government drug suppliers, and under these agreements, VLNS will supply PMI with both CBD oil and prebiotic products. Valens’ CBD products will support ongoing pharmacokinetic stage medical studies and Valens will also develop and distribute CBD-infused and non-infused products in Mexico. According to VLNS, “The relationship we have established with PMI Mexico is an important milestone in Valens’ international expansion and the beginning of our strategy for Central and Latin America. This agreement diversifies our global strategy and increases our revenue streams through creative, non-traditional strategies, that separate us. ” from our colleagues. “

Later in the week The Valens Company Inc. signed a partnership with Montreal Cannabis Médical Inc. on Wednesday to provide the manufacturing and extraction services for MTL’s pre-rolls and vapes. The contract is due to start at the end of the first quarter of next year.

On Tuesday, Organigram Holdings Inc. (NASDAQ: OGI) confirmed the acquisition of Laurentian Organic Inc for a total of $ 36 million in a transaction aimed at further strengthening OGI’s position in the Canadian cannabis market. The deal will add premium hash and craft cannabis product lines to Organigram’s portfolio. OGI is committed to significant growth in the HS industry and expects these newly acquired products to grow rapidly in Canada.

As Tilray (NASDAQ: TLRY) Continuing its mission to be operational after federal legalization in the United States, TLRY announced on Tuesday that it had acquired Green Flash Brewing and Alpine Beer Co. This happens just a few weeks after Tilray took over Breckenridge Distillery. The plan behind these alcoholic beverages acquisitions is to focus on scaling these brands that could increase the potential distribution of cannabis products after state legalization.

* NEW CANNABIS STOCK ALARM * On Wednesday, BAD ETF (NYSE: BAD) started trading on the New York Stock Exchange. This exchange traded fund, launched by The BAD Investment Company, is an index that focuses on gambling, alcohol and cannabis stocks. According to the founder of the BAD investment company “We don’t believe that social stigma should be a primary factor in deciding what is a good investment.”